FENC
Fennec Pharmaceuticals Inc
NASDAQ: FENC · HEALTHCARE · BIOTECHNOLOGY
$10.96
-3.01% today
Updated 2026-09-11
Market cap
$433.08M
P/E ratio
—
P/S ratio
7.31x
EPS (TTM)
$-0.12
Dividend yield
—
52W range
$6 – $13
Volume
0.2M
Fennec Pharmaceuticals Inc (FENC) Insider transactions
Net insider activity
Net buying (799,707 shares)
Buy transactions
75
Sell transactions
25
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-01 | RAYKOV, ROSTY | Former Director | Sale | 10,000 | $12.11 | $121100.00 |
| 2026-08-31 | SAYAD, PIERRE SARGIS | Chief Medical Officer | Sale | 12,000 | $12.18 | $146160.00 |
| 2026-08-31 | SAYAD, PIERRE SARGIS | Chief Medical Officer | Buy | 168 | — | — |
| 2026-08-31 | RAYKOV, ROSTY | Former Director | Buy | 2,778 | — | — |
| 2026-08-31 | HACKMAN, JEFFREY S. | Director, Chief Executive Officer | Buy | 1,159 | — | — |
| 2026-08-31 | EVANS, TERRY L | Chief Commercial Officer | Buy | 168 | — | — |
| 2026-08-31 | CIOFFI, CHRISTIANA MARIE | Chief Strategy Officer | Buy | 156 | — | — |
| 2026-08-31 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 1,703 | — | — |
| 2026-08-28 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Sale | 21,928 | — | — |
| 2026-08-28 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 21,928 | $5.10 | $111832.80 |
| 2026-08-27 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Sale | 75,000 | $11.78 | $883500.00 |
| 2026-08-03 | RAYKOV, ROSTY | Former Director | Sale | 10,000 | $9.58 | $95800.00 |
| 2026-07-31 | SAYAD, PIERRE SARGIS | Chief Medical Officer | Buy | 168 | — | — |
| 2026-07-31 | RAYKOV, ROSTY | Former Director | Buy | 2,778 | — | — |
| 2026-07-31 | HACKMAN, JEFFREY S. | Director, Chief Executive Officer | Buy | 1,159 | — | — |
| 2026-07-31 | EVANS, TERRY L | Chief Commercial Officer | Buy | 168 | — | — |
| 2026-07-31 | CIOFFI, CHRISTIANA MARIE | Chief Strategy Officer | Buy | 156 | — | — |
| 2026-07-31 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 1,703 | — | — |
| 2026-07-01 | RAYKOV, ROSTY | Former Director | Sale | 15,597 | $2.45 | $38212.65 |
| 2026-07-01 | RAYKOV, ROSTY | Former Director | Buy | 15,597 | $2.45 | $38212.65 |
| 2026-07-01 | RAYKOV, ROSTY | Former Director | Sale | 9,599 | $10.41 | $99925.59 |
| 2026-07-01 | RAYKOV, ROSTY | Former Director | Buy | 2,778 | — | — |
| 2026-06-30 | SAYAD, PIERRE SARGIS | Chief Medical Officer | Buy | 168 | — | — |
| 2026-06-30 | HACKMAN, JEFFREY S. | Director, Chief Executive Officer | Buy | 1,159 | — | — |
| 2026-06-30 | EVANS, TERRY L | Chief Commercial Officer | Buy | 168 | — | — |
| 2026-06-30 | CIOFFI, CHRISTIANA MARIE | Chief Strategy Officer | Buy | 156 | — | — |
| 2026-06-30 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 1,703 | — | — |
| 2026-06-10 | RALLIS, CHRIS A | Director | Buy | 20,000 | $8.70 | $174000.00 |
| 2026-06-10 | ISLAM, KHALID | Director | Buy | 25,000 | $8.70 | $217500.00 |
| 2026-06-10 | COOK, JODI A | Director | Buy | 20,000 | $8.70 | $174000.00 |
| 2026-06-10 | BRUGHERA, MARCO MARIA | Director | Buy | 20,000 | $8.70 | $174000.00 |
| 2026-06-01 | RAYKOV, ROSTY | Director | Sale | 15,597 | $2.45 | $38212.65 |
| 2026-06-01 | RAYKOV, ROSTY | Director | Buy | 15,597 | $2.45 | $38212.65 |
| 2026-06-01 | RAYKOV, ROSTY | Director | Sale | 9,747 | $9.62 | $93766.14 |
| 2026-05-31 | SAYAD, PIERRE SARGIS | Chief Medical Officer | Buy | 168 | — | — |
| 2026-05-31 | RAYKOV, ROSTY | Director | Buy | 2,778 | — | — |
| 2026-05-31 | HACKMAN, JEFFREY S. | Director, Chief Executive Officer | Buy | 1,159 | — | — |
| 2026-05-31 | EVANS, TERRY L | Chief Commercial Officer | Buy | 168 | — | — |
| 2026-05-31 | CIOFFI, CHRISTIANA MARIE | Chief Strategy Officer | Buy | 156 | — | — |
| 2026-05-31 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 1,703 | — | — |
| 2026-05-11 | RALLIS, CHRIS A | Director | Sale | 14,344 | $2.44 | $34999.36 |
| 2026-05-11 | RALLIS, CHRIS A | Director | Buy | 14,344 | $2.44 | $34999.36 |
| 2026-05-11 | RALLIS, CHRIS A | Director | Sale | 8,346 | $7.04 | $58755.84 |
| 2026-05-01 | RAYKOV, ROSTY | Director | Sale | 15,598 | $2.45 | $38215.10 |
| 2026-05-01 | RAYKOV, ROSTY | Director | Buy | 15,598 | $2.45 | $38215.10 |
| 2026-05-01 | RAYKOV, ROSTY | Director | Sale | 10,781 | $6.47 | $69753.07 |
| 2026-04-30 | SAYAD, PIERRE SARGIS | Chief Medical Officer | Buy | 168 | — | — |
| 2026-04-30 | RAYKOV, ROSTY | Director | Buy | 2,778 | — | — |
| 2026-04-30 | HACKMAN, JEFFREY S. | Director, Chief Executive Officer | Buy | 1,159 | — | — |
| 2026-04-30 | EVANS, TERRY L | Chief Commercial Officer | Buy | 168 | — | — |
| 2026-04-30 | CIOFFI, CHRISTIANA MARIE | Chief Strategy Officer | Buy | 155 | — | — |
| 2026-04-30 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 1,703 | — | — |
| 2026-04-01 | RAYKOV, ROSTY | Director | Sale | 15,598 | $2.45 | $38215.10 |
| 2026-04-01 | RAYKOV, ROSTY | Director | Buy | 15,598 | $2.45 | $38215.10 |
| 2026-04-01 | RAYKOV, ROSTY | Director | Sale | 10,946 | $6.31 | $69069.26 |
| 2026-03-31 | SAYAD, PIERRE SARGIS | Chief Medical Officer | Buy | 120,000 | $5.77 | $692400.00 |
| 2026-03-31 | SAYAD, PIERRE SARGIS | Chief Medical Officer | Buy | 18,456 | — | — |
| 2026-03-31 | SAYAD, PIERRE SARGIS | Chief Medical Officer | Buy | 171 | — | — |
| 2026-03-31 | RAYKOV, ROSTY | Director | Buy | 5,208 | — | — |
| 2026-03-31 | HACKMAN, JEFFREY S. | Director, Chief Executive Officer | Buy | 200,000 | $5.77 | $1.15M |
| 2026-03-31 | HACKMAN, JEFFREY S. | Director, Chief Executive Officer | Buy | 16,695 | — | — |
| 2026-03-31 | HACKMAN, JEFFREY S. | Director, Chief Executive Officer | Buy | 1,159 | — | — |
| 2026-03-31 | EVANS, TERRY L | Chief Commercial Officer | Buy | 120,000 | $5.77 | $692400.00 |
| 2026-03-31 | EVANS, TERRY L | Chief Commercial Officer | Buy | 18,456 | — | — |
| 2026-03-31 | EVANS, TERRY L | Chief Commercial Officer | Buy | 171 | — | — |
| 2026-03-31 | CIOFFI, CHRISTIANA MARIE | Chief Strategy Officer | Buy | 120,000 | $5.77 | $692400.00 |
| 2026-03-31 | CIOFFI, CHRISTIANA MARIE | Chief Strategy Officer | Buy | 17,106 | — | — |
| 2026-03-31 | CIOFFI, CHRISTIANA MARIE | Chief Strategy Officer | Buy | 158 | — | — |
| 2026-03-31 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 120,000 | $5.77 | $692400.00 |
| 2026-03-31 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 14,724 | — | — |
| 2026-03-31 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 2,213 | — | — |
| 2026-03-28 | SAYAD, PIERRE SARGIS | Chief Medical Officer | Buy | 2,052 | — | — |
| 2026-03-28 | HACKMAN, JEFFREY S. | Director, Chief Executive Officer | Buy | 13,943 | — | — |
| 2026-03-28 | EVANS, TERRY L | Chief Commercial Officer | Buy | 2,052 | — | — |
| 2026-03-28 | CIOFFI, CHRISTIANA MARIE | Chief Strategy Officer | Buy | 1,901 | — | — |
| 2026-03-28 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 12,270 | — | — |
| 2026-03-26 | CIOFFI, CHRISTIANA MARIE | Chief Strategy Officer | Sale | 4,700 | $4.23 | $19881.00 |
| 2026-03-26 | CIOFFI, CHRISTIANA MARIE | Chief Strategy Officer | Buy | 4,700 | $4.23 | $19881.00 |
| 2026-03-26 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Sale | 13,072 | $5.10 | $66667.20 |
| 2026-03-26 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 13,072 | $5.10 | $66667.20 |
| 2026-03-02 | RAYKOV, ROSTY | Director | Sale | 15,598 | $2.45 | $38215.10 |
| 2026-03-02 | RAYKOV, ROSTY | Director | Buy | 15,598 | $2.45 | $38215.10 |
| 2026-03-02 | RAYKOV, ROSTY | Director | Sale | 10,079 | $8.36 | $84260.44 |
| 2026-02-28 | RAYKOV, ROSTY | Director | Buy | 5,208 | — | — |
| 2026-02-28 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 1,191 | — | — |
| 2026-02-18 | HACKMAN, JEFFREY S. | Director, Chief Executive Officer | Buy | 13,710 | — | — |
| 2026-02-18 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Sale | 2,450 | $4.08 | $9996.00 |
| 2026-02-18 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 27,285 | — | — |
| 2026-02-18 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 2,450 | $4.08 | $9996.00 |
| 2026-02-02 | RAYKOV, ROSTY | Director | Sale | 15,598 | $2.45 | $38215.10 |
| 2026-02-02 | RAYKOV, ROSTY | Director | Buy | 15,598 | $2.45 | $38215.10 |
| 2026-02-02 | RAYKOV, ROSTY | Director | Sale | 10,349 | $7.76 | $80308.24 |
| 2026-01-31 | RAYKOV, ROSTY | Director | Buy | 5,208 | — | — |
| 2026-01-31 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 1,558 | — | — |
| 2026-01-23 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Sale | 10,000 | $2.45 | $24500.00 |
| 2026-01-23 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 10,000 | $2.45 | $24500.00 |
| 2026-01-15 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Sale | 10,000 | $2.45 | $24500.00 |
| 2026-01-15 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 10,000 | $2.45 | $24500.00 |
| 2026-01-07 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Sale | 14,184 | $2.45 | $34750.80 |
| 2026-01-07 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 14,184 | $2.45 | $34750.80 |
Frequently asked questions
Are FENC insiders buying or selling?
Over the transactions on record, FENC insiders have been net buyers, with about $2.25M in stock sold across 25 sales, against 23 open-market purchases.
Does insider selling at FENC mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which FENC insiders are selling the most?
Recent selling is concentrated in a few names. ANDRADE, ROBERT accounts for the largest share on record, with about $1.04M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.